PRF Technologies (PRFX) Total Non-Current Liabilities (2019 - 2026)
PRF Technologies' (PRFX) quarterly Total Non-Current Liabilities came in at $271000.0 in Q2 2026, up 3.04% on a YoY basis from $263000.0 in Q2 2025, and up 1.5% quarter-over-quarter from $267000.0 in Q4 2025.
PRF Technologies (PRFX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
PRF Technologies (PRFX) has reported Total Non-Current Liabilities for 8 consecutive years, with $271000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 3.04% year-over-year to $271000.0; the trailing twelve-month figure through Jun 2026 stood at $271000.0 (up 3.04% YoY), and the FY2025 full-year result was $267000.0, up 3.09% from the prior year.
- Total Non-Current Liabilities grew to $271000.0 in Q2 2026 per PRFX's latest filing, from $267000.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.2 million in Q3 2023 and bottomed at $236000.0 in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $414692.3 across 5 years, with a median of $263000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities jumped 367.08% in 2023, then plunged 77.18% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $243000.0 in 2022, then jumped by 367.08% to $1.1 million in 2023, then slumped by 77.18% to $259000.0 in 2024, then climbed by 3.09% to $267000.0 in 2025, then grew by 1.5% to $271000.0 in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $271000.0, $267000.0, and $263000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 16.45 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 18.76 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 1.29 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 2.78 Bn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 24.86 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 881.37 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 1.45 Bn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 946.17 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 20.92 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | 271,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 271,000.00 |
| Dec 31, 2025 | 267,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Jun 30, 2024 | 257,000.00 |
| Mar 31, 2024 | 268,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 247,000.00 |
| Mar 31, 2023 | 245,000.00 |
| Dec 31, 2022 | 243,000.00 |
| Jun 30, 2022 | 549,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 213,000.00 |
| Dec 31, 2020 | 220,000.00 |
| Sep 30, 2020 | -1.07 Mn |
| Jun 30, 2020 | 1.51 Mn |
| Mar 31, 2020 | -802,000.00 |
PRF Technologies Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRFX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();